Dana Yaacov-Garbeli
CIK 1909822 · Chief Financial Officer · last filed 2026-05-08
Dana Yaacov-Garbeli is a Chief Financial Officer who has filed 7 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ENTX, was dated May 8, 2026. Across all open-market trades the lifetime net is +$29.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $317.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$317.6K
2
7
$29.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTX | Chief Financial Officer | 258,172 | $1.23 | $317.6K | $0 | 4 | 2026-05-08 |
| Entera Bio Ltd. (ENTXW) Delisted | Chief Financial Officer | 30,000 | $0.00 | $36 | $29.8K | 3 | 2023-04-25 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-08 | ENTX | Grant (A) | +58,394 | $0 | EDGAR |
| 2025-07-18 | ENTX | Grant (A) | +26,316 | $0 | EDGAR |
| 2024-08-02 | ENTX | Grant (A) | +30,151 | $0 | EDGAR |
| 2024-04-23 | ENTX | Grant (A) | +30,151 | $0 | EDGAR |
| 2023-04-25 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-15 | Entera Bio Ltd. (ENTXW) Delisted | Buy (P) | +56,580 | $29.8K | EDGAR |
| 2022-09-09 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |